Si Hyung Lee, Min Cheol Kim, Seong Woo Jeon, Kang Nyeong Lee, Jong Jae Park, Su Jin Hong, Korean Society of Gastrointestinal Endoscopy Endoscopic Submucosal Dissection Research Group
Clin Endosc 2020;53(2):196-205. Published online October 25, 2019
Background /Aims: The purpose of this study was to investigate the risk factors and long-term clinical outcomes of non-curative resection (NCR) in a large-scale patient population.
Methods We retrospectively analyzed the clinical data of 3,094 patients who underwent endoscopic submucosal dissection (ESD) of early gastric cancer from March 2005 to March 2018 at 13 institutions in Korea. We analyzed the risk factors for NCR and the survival between patients with curative resection and those with NCR with no additional treatment.
Results The NCR rate was 21.4% (661/3,094). In multivariate regression analysis, the risk factors affecting NCR with ESD were old age, undifferentiated tumor, tumor location in the upper body, tumor size ≥2 cm, and presence of an ulcer. In Cox proportional hazard regression analysis, tumor size ≥2 cm, submucosal invasion, positive horizontal margin, and lymphovascular invasion were risk factors for local recurrence. In Kaplan-Meier analysis, there was no statistically significant difference in the overall survival between the two groups (log-rank p=0.788). However, disease-specific survival was significantly lower in the NCR group (log-rank p=0.038).
Conclusions Clinicians should be aware of the risk factors for NCR and local recurrence after ESD for early gastric cancer, and should consider providing additional treatment after NCR.
Citations
Citations to this article as recorded by
Management Strategy of Non-curative ESD in Gastric Cancer: Curative Criteria, and the Critical Building Block for Determining Beyond It Hyuk Lee Journal of Gastric Cancer.2025; 25(1): 210. CrossRef
Enhancing Lymph Node Metastasis Risk Prediction in Early Gastric Cancer Through the Integration of Endoscopic Images and Real-World Data in a Multimodal AI Model Donghoon Kang, Han Jo Jeon, Jie-Hyun Kim, Sang-Il Oh, Ye Seul Seong, Jae Young Jang, Jung-Wook Kim, Joon Sung Kim, Seung-Joo Nam, Chang Seok Bang, Hyuk Soon Choi Cancers.2025; 17(5): 869. CrossRef
Risk factors for pathological upgrading and noncurative resection in patients with gastric mucosal lesions after endoscopic submucosal dissection Pingjiang Wang, Xu Zhao, Ruicai Wang, Dong Xu, Haiping Yang BMC Gastroenterology.2024;[Epub] CrossRef
Endoscopic and clinicopathological features of early gastric papillary adenocarcinoma Zhenxiang Zuo, Xing Qi, Xiujie Cui, Bin Yu, Huimin Zhang, Honglei Wu Frontiers in Oncology.2024;[Epub] CrossRef
Comprehensive analysis of risk factors associated with submucosal invasion in patients with early-stage gastric cancer Bin-Bin Yan, Li-Na Cheng, Hui Yang, Xiu-Ling Li, Xiu-Qi Wang World Journal of Gastroenterology.2024; 30(47): 5007. CrossRef
Pathology Reporting of Gastric Endoscopic Resections: Recommendations From the International Collaboration on Cancer Reporting Chanjuan Shi, Fleur Webster, Iris D. Nagtegaal, Michael J. Bourke, Seung-mo Hong, M. Priyanthi Kumarasinghe, Alfred K. Lam, Gregory Lauwers, Maria O’Donovan, Rachel S. van der Post, Tetsuo Ushiku, Michael Vieth, Christina Selinger Gastroenterology.2023; 164(7): 1039. CrossRef
Nomogram for pre-procedural prediction of non-curative endoscopic resection in patients with early gastric cancer So Young Han, Hong Jin Yoon, Jie-Hyun Kim, Hye Sun Lee, Jaeyoung Chun, Young Hoon Youn, Hyojin Park Surgical Endoscopy.2023; 37(6): 4594. CrossRef
Endoscopic submucosal dissection for early gastric cancer: It is time to consider the quality of its outcomes Gwang Ha Kim World Journal of Gastroenterology.2023; 29(43): 5800. CrossRef
Cancer Patient Perception Survey to Develop Korean Medicine Clinical Practice Guidelines for Gastric Cancer Dong Hyeon Kim, Jong Hee Kim, Ji Hye Park, Hwa Seung Yoo, Hyeong Joon Jeon, So Jung Park Journal of Physiology & Pathology in Korean Medicine.2023; 37(4): 81. CrossRef
Endoscopic treatment for early gastric cancer Ji Yong Ahn Journal of the Korean Medical Association.2022; 65(5): 276. CrossRef
Therapeutic approach to non-curative resection after endoscopic treatment in early gastric cancer Eun Jeong Gong, Chang Seok Bang Journal of the Korean Medical Association.2022; 65(5): 284. CrossRef
Endoscopic diagnosis of early gastric cancer Dong Chan Joo, Gwang Ha Kim Journal of the Korean Medical Association.2022; 65(5): 267. CrossRef
Long‑term outcome of the endoscopic submucosal dissection of early gastric cancer: A comparison between patients with and without liver cirrhosis Seung Kim, Moon Joo, Ah-Young Yoo, Seong Kim, Won Kim, Beom Lee, Jong Park, Hoon Chun, Sang Lee Oncology Letters.2022;[Epub] CrossRef
Clinico-pathologic determinants of non-e-curative outcome following en-bloc endoscopic submucosal dissection in patients with early gastric neoplasia Kidane Siele Embaye, Chao Zhang, Matiwos Araya Ghebrehiwet, Zhihao Wang, Fengdi Zhang, Liwei Liu, Shenghui Qin, Lingzhi Qin, Jun Wang, Xi Wang BMC Cancer.2021;[Epub] CrossRef
Factors associated with overall survival in early gastric cancer patients who underwent additional surgery after endoscopic submucosal dissection Zhi Zheng, Fan-Di Bu, Hao Chen, Jie Yin, Rui Xu, Jun Cai, Jun Zhang, Hong-Wei Yao, Zhong-Tao Zhang World Journal of Clinical Cases.2021; 9(10): 2192. CrossRef
Establishing Machine Learning Models to Predict Curative Resection in Early Gastric Cancer with Undifferentiated Histology: Development and Usability Study Chang Seok Bang, Ji Yong Ahn, Jie-Hyun Kim, Young-Il Kim, Il Ju Choi, Woon Geon Shin Journal of Medical Internet Research.2021; 23(4): e25053. CrossRef
Population Attributable Fraction of Helicobacter pylori Infection–Related Gastric Cancer in Korea: A Meta-Analysis Yoon Park, Moran Ki Cancer Research and Treatment.2021; 53(3): 744. CrossRef
Very low rate of residual neoplasia after non-curative endoscopic submucosal dissection: a western single-center experience João Santos-Antunes, Margarida Marques, Fátima Carneiro, Guilherme Macedo European Journal of Gastroenterology & Hepatology.2021; 33(9): 1161. CrossRef
Editors' Choice of Noteworthy Clinical Endoscopy Publications in the First Decade Gwang Ha Kim, Kwang An Kwon, Do Hyun Park, Jimin Han Clinical Endoscopy.2021; 54(5): 633. CrossRef
Non-Curative Resection: Should Clinicians Consider Providing Additional Surgery for All Patients?
Waku Hatta, Takuji Gotoda, Atsushi Masamune Clinical Endoscopy.2020; 53(2): 109. CrossRef
Protocol for expanded indications of endoscopic submucosal dissection for early gastric cancer in China: a multicenter, ambispective, observational, open-cohort study Zhi Zheng, Jie Yin, Ziyu Li, Yingjiang Ye, Bo Wei, Xin Wang, Yantao Tian, Mengyi Li, Qian Zhang, Na Zeng, Rui Xu, Guangyong Chen, Jie Zhang, Peng Li, Jun Cai, Hongwei Yao, Jun Zhang, Zhongtao Zhang, Shutian Zhang BMC Cancer.2020;[Epub] CrossRef
Predictive Factors and Long-Term Outcomes of Early Gastric Carcinomas in Patients with Non-Curative Resection by Endoscopic Submucosal Dissection
Hyo Jung Kim, M.D., Sung Tae Kim, M.D., Sang Woo Lee, M.D., Yoon Tae Jeen, M.D.,Hoon Jai Chun, M.D., Hong Sik Lee, M.D., Chi Wook Song, M.D.,Soon Ho Um, M.D., Jai Hyun Choi, M.D., Chang Duck Kim, M.D.,Ho Sang Ryu, M.D. and Jin Hai Hyun, M.D.
Korean J Gastrointest Endosc 2001;22(4):202-207. Published online April 30, 2001
Background /Aims: Follow-up studies with low sensitivity and specificity make it difficult to predict precisely long-term effect of H. pylori eradication therapy. The aim of this prospective study was to evaluate the usefulness of Giemsa staining and CLO test following eradication therapy. Methods: In this study, H. pylori eradication therapy was done in 99 consecutive peptic ulcer patients and followed at 1, 6, and 12 months. Follow-up diagnosis was performed by Giemsa staining and CLO test using 6 specimens taken from the gastric antrum and midbody. Eradication was considered if the results of the two tests were negative. Results: Overall the results of 63 (64%) patients among 99 patients who followed more than 6 months did not changed including 9 persistent positive, and 54 negative. However, the result of 36 patients changed to 21 positive and 15 negative conversion after 6 months. The estimated sensitivity, specificity, positive predictive value, negative predictive value of the Giemsa staining and CLO test, using PCR and culture as 'gold standard', were 67%, 85%, 82%, 70%, respectively. Conclusions: Sensitivity and specificity of Giemsa staining and CLO test following eradication therapy are lower than other reports. It is suggested that the large, multicenter prospective study is necessary to prove diagnostic accuracy of those follow-up studies. (Korean J Gastrointest Endosc 2001; 22:202207)
Background /Aims: A villous tumor, histologically villous or tubulovillous adenoma, is a clinical challenge because of its higher potential for malignancy and higher recurrence rate. However, information and experience with these tumors in the Korean people is still lacking. For that reason, we designed this study to review and analyze the colonoscopic features, the potential for malignancy, and the treatiment with respect to the confirmation of guidelines for the accurate diagnosis and reasonable management of such tumors in the Korean population. Materials and Methods: We performed 753 polypectomies, including 4 transanal excisions and several bowel resections, from January 1996 to May 1997 at Song-Do Colorectal Hospital in Seoul, Among them, 447 cases (59.4%) were adenomas, comprising 405 (53.8%) tubular adenomas, 31 (4.1%) tubulovillous adenomas, and 11 (1.5%) villous adenomas. We analyzed the 42 (5.6%) tubulovillous and villous adenomas. (Korean J Gastraintest Endosc 18: 506-519, 1998) (continue)